NCM Boston | Oxford Nanopore Technologies
NCM Boston
Oxford Nanopore Technologies
Sebastian B. Teitz
![.](https://a.storyblok.com/f/196663/1024x1024/0c05d52969/sebastian-teitz.jpg/m/350x0/filters:format(webp))
- Job title
- Institution
- veryTeitz Consulting, Germany
- Biography
David has been with Regeneron Pharmaceuticals in QC virology since 2015. As the principal scientist he spearheaded the development of NGS-based assays for adventitious agent GMP testing. Currently, he leads a team of eight researchers continuing to modernize QC virology testing using NGS in the GMP space.
- Recent publications
Armstrong, A. et al. Seven Key Takeaways from PDA’s Viral Safety for ATMPs Workshop and Virus Conference Events. PDA Letter.
pda.org/pda-letter-portal/home/full-article/seven-keytakeaways-from-pda-s-viral-safety-for-atmps-workshop-and-virus-conference-events (2023)
[Accessed: 25 July 2024]Koenigsberg, A.L. et al. MIT CAACB Risk Assessment Case Study: Assessing Virus Cross-Contamination Risk between Two Simultaneous Processes in an Open Biomanufacturing Facility. PDA J Pharm Sci Technol. 77(2):115–132 (2023).
DOI: 10.5731/pdajpst.2021.012691Yue, C. et al. Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products. Viruses. 11(3):234 (2019).
DOI: 10.3390/v11030234